Marlies E J Reinders

19PUBLICATIONS
68CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Nephrology and urologyToxicology (incl. clinical toxicology)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 15, 2025
Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation.

Lukas K van Vugt, Tom C Zwart, Suzanne Bezstarosti

|Mar 06, 2025
Limited Risk of Microbial Contamination During Hypothermic and Normothermic Machine Perfusion of Donor Kidneys.

Julia S Slagter, Carolina A M Schurink, Ga-Lai M Chong

|Jan 30, 2025
Long-term Double-J stenting is superior to short-term Single-J stenting in kidney transplantation.

Christiaan A J Oudmaijer, Kelly Muller, Erika van Straalen

|Dec 05, 2024
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant Rejection.

Lukas K van Vugt, Erzsi Tegzess, Marieke van der Zwan

|Jun 03, 2024
Removing the physician from the equation: Patient-controlled, home-based therapeutic drug self-monitoring of tacrolimus.

Marinus Hazenbroek, Liset H M Pengel, Sebastiaan D T Sassen

|Feb 26, 2023
HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.

Suzanne Bezstarosti, Soufian Meziyerh, Marlies E J Reinders

Pageof 4

Frequent Collaborators

6 joint publications

Peter G M de Jong

4 joint publications

Renée A Hendriks

4 joint publications

Aiko P J de Vries

4 joint publications

Koen E Groeneweg